Clinical Trial Update: Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer [Phase 3]

View source ↗

Summary

This document reports a completed Phase 3 trial comparing atezolizumab with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in early-relapse ov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: AGO Research GmbH | Conditions: Recurrent Ovarian Carcinoma | Phase 3 | Status: COMPLETED